Barclays analyst Lauren Lieberman raised the firm’s price target on Clorox (CLX) to $140 from $130 and keeps an Underweight rating on the shares. The company’s enterprise resource planning implementation should drive margin growth, but sales growth “remains an open question and will be for some time,” the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX: